Esperion Therapeutics: Q2 Earnings Snapshot – mySA

ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $66.3 million in its second quarter.

The Ann Arbor, Michigan-based company said it had a loss of $1.05 per share.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.

The biopharmaceutical company posted revenue of $18.8 million in the period, also falling short of Street forecasts. Six analysts surveyed by Zacks expected $19.3 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ESPR at

Original News Source